Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 4, 2009, Pages 641-644

  Södergren, Anna ^a   Stegmayr, B ^b   Ohman M L ^a   Wallberg Jonsson S ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cardiovascular disease; Cerebrovascular disorders; Morbidity; Rheumatoid arthritis

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE REGISTRY; FATALITY; FEMALE; FOLLOW UP; HUMAN; MALE; MORBIDITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; STROKE; SWEDEN;

AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; STROKE; SURVIVAL RATE; SWEDEN;

EID: 70350159890     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. WOLFE F, MITCHELL DM, SIBLEY JT et al.: The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-494
2. WÅLLBERG-JONSSON S, ÖHMAN M-L, RANTAPÄÄ-DAHLQVIST S: Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997; 24: 445-451
3. WATSON DJ, RHODES T, GUESS HA: All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003; 30: 1196-1202
4. LÉVY L, FAUTREL B, BARNETCHE T, SCHAEVERBEKE T: Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 2008; 26: 673-679
5. DEL RINCÓN ID, WILLIAMS K, STERN MP, FREEMAN GL, ESCALANTE A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-2745
6. SÖDERGREN A, STEGMAYR B, LUNDBERG V, ÖHMAN M-L, WÅLLBERG-JONSSON S: Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007; 66: 263-266
7. SOLOMON DH, KARLSON EW, RIMM EB et al.: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-1307
8. SOLOMON DH, GOODSON NJ, KATZ JN et al.: Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1608-1612
9. BOERS M, DIJKMANS B, GABRIEL S, MARADIT-KREMERS H, O'DELL J, PINCUS T: Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. Arthritis Rheum 2004; 50: 1734-1739
10. DEL RINCÓN I, FREEMAN GL, HAAS RW, OLEARY DH, ESCALANTE A: Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005; 52: 3413-3423 (Pubitemid 41612207)
11. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, LOPEZ-DIAZ MJ et al.: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-132
12. VAN DOORNUM S, BRAND C, KING B, SUNDARARAJAN V: Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54: 2061-2068
13. NADAREISHVILI Z, MICHAUD K, HALLENBECK JM, WOLFE F: Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008; 59: 1090-1096
14. STEGMAYR B, LUNDBERG V, ASPLUND K: The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003; 61: 9-17.
15. WÅLLBERG-JONSSON S, JOHANSSON H, ÖHMAN ML, RANTAPÄÄ-DAHLQVIST S: Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999; 26: 2562-2571
16. ROSS R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
17. JACOBSSON LT, TURESSON C, GÜLFE A et al.: Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1213-1218
18. HANKEY GJ, SPIESSER J, HAKIMI Z, BEGO G, CARITA P, GABRIEL S: Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology 2007; 68: 1583-1587 (Pubitemid 46717982)